Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Urogenital Neoplasms 1Gastric Adenocarcinoma 1Erectile Dysfunction 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2Gastrectomy 2taxane 1sintilimab 1XELOX 1Tegafur 1Taxes 1Tadalafil 1Platinum 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Immunotherapy, Adoptive 1Drug Therapy 1Cytoreduction Surgical Procedures 1Cisplatin 1Capecitabine 1Albumin-Bound Paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gastric Adenocarcinoma × Tadalafil × Clear all
NCT05709574 2025-10-16

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

University of Arizona

Phase 2 Recruiting
10 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡